Trial Profile

Phase Ib Clinical Trial Evaluating the Safety and Immunogenicity of Freeze-dried Recombinant Tuberculosis Vaccine (AEC / BC02) in Healthy Adults

Status: Completed

Phase of Trial: Phase I

Latest Information Update: 08 Sep 2022

Price :

$35 ^*

Note:

Adis is an information provider.
Final gross price and currency may vary according to local VAT and billing address.
Your purchase entitles you to full access to the information contained in our trial profile at the time of purchase.
A link to download a PDF version of the trial profile will be included in your email receipt.

At a glance

Drugs Mycobacterium riyadhense (Primary)
Indications Tuberculosis
Focus Adverse reactions
Sponsors Anhui Zhifei Longcom Biopharmaceutical

Most Recent Events

02 Sep 2022 Status changed from active, no longer recruiting to completed.
21 Feb 2022 Planned End Date changed from 30 Aug 2021 to 30 Apr 2022.
26 May 2021 Planned primary completion date changed from 31 Dec 2020 to 31 Jul 2021.

You need to be a logged in or subscribed to view this content

If your organization or you do not have a subscription, try one of the following:

Contacting your organization’s admin about adding this content to your AdisInsight subscription
Buying a PDF version of any individual profile
Request a free trial (opens in a new window)

If your organization has a subscription, there are several access options, even while working remotely:

Working within your organization’s network
Login with username/password or try to access via your institution
Persisted access using your organization’s identifier stored in your user browser for 90 days

For assistance, contact us at asktheexpert.adisinsight@springer.com